Lisa M. Anderson
Known title: SVP, General Counsel &Corp SecCIK: 0001913951
Associated companies
Transaction History
| IEX | ▲ Buy | Option Exercise | 385 | $36K | 8/12/2026 | View on chart |
| IEX | ▼ Sell | Open Market | 385 | $92K | 8/12/2026 | View on chart |
| IEX | ▲ Buy | Grant | 1,205 | $0 | 2/19/2026 | View on chart |
| IEX | ▲ Buy | Grant | 1,025 | $0 | 2/20/2025 | View on chart |
| IEX | ▲ Buy | Grant | 862 | $169K | 2/11/2025 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 413 | $81K | 2/11/2025 | View on chart |
| IEX | ▲ Buy | Grant | 205 | $47K | 2/13/2024 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 102 | $23K | 2/13/2024 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 134 | $31K | 2/21/2023 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 260 | $60K | 2/18/2023 | View on chart |
| IEX | ▲ Buy | Grant | 528 | $122K | 2/18/2023 | View on chart |
| IEX | ▼ Sell | Tax Withholding | 112 | $21K | 3/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
IDEX price target raised to $285 by RBC Capital
RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.
IDEX price target raised to $285 by RBC Capital. RBC Capital has kept its outperform rating on IDEX and lifted the target price to $285, reflecting confidence in the company's earnings outlook. The move comes as the stock trades near the upper end of its 52‑week range and shows a moderately strong RSI of 63.3. Analysts see the firm’s valuation as still attractive compared to peers. The update may influence how investors view IDEX’s growth prospects.